These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14504108)

  • 1. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
    Damle RN; Batliwalla FM; Ghiotto F; Valetto A; Albesiano E; Sison C; Allen SL; Kolitz J; Vinciguerra VP; Kudalkar P; Wasil T; Rai KR; Ferrarini M; Gregersen PK; Chiorazzi N
    Blood; 2004 Jan; 103(2):375-82. PubMed ID: 14504108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
    Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
    Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
    Palma M; Parker A; Hojjat-Farsangi M; Forster J; Kokhaei P; Hansson L; Osterborg A; Mellstedt H
    Exp Hematol; 2013 Jul; 41(7):615-26. PubMed ID: 23548418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length and heavy-chain mutation status in familial chronic lymphocytic leukemia.
    Ishibe N; Prieto D; Hosack DA; Lempicki RA; Goldin LR; Raffeld M; Marti GE; Caporaso NE
    Leuk Res; 2002 Sep; 26(9):791-4. PubMed ID: 12127552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
    Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
    Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeres and prognosis in patients with chronic lymphocytic leukaemia.
    Sellmann L; de Beer D; Bartels M; Opalka B; Nückel H; Dührsen U; Dürig J; Seifert M; Siemer D; Küppers R; Baerlocher GM; Röth A
    Int J Hematol; 2011 Jan; 93(1):74-82. PubMed ID: 21203871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
    Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
    Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
    Roos G; Kröber A; Grabowski P; Kienle D; Bühler A; Döhner H; Rosenquist R; Stilgenbauer S
    Blood; 2008 Feb; 111(4):2246-52. PubMed ID: 18045969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory parameters that define clinically relevant B-CLL subgroups.
    Chiorazzi N; Allen SL; Ferrarini M
    Curr Top Microbiol Immunol; 2005; 294():109-33. PubMed ID: 16329193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
    Capello D; Fais F; Vivenza D; Migliaretti G; Chiorazzi N; Gaidano G; Ferrarini M
    Leukemia; 2000 May; 14(5):811-5. PubMed ID: 10803511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
    Olbertova H; Plevova K; Pavlova S; Malcikova J; Kotaskova J; Stranska K; Spunarova M; Trbusek M; Navrkalova V; Dvorackova B; Tom N; Pal K; Jarosova M; Brychtova Y; Panovska A; Doubek M; Pospisilova S
    BMC Cancer; 2022 Feb; 22(1):137. PubMed ID: 35114947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia.
    Brezinova J; Berkova A; Vcelikova S; Zemanova Z; Izakova S; Sarova I; Cechova H; Tajtlova J; Grosova L; Lizcova L; Malinova E; Zemanova M; Cmunt E; Karban J; Trneny M; Schwarz J; Michalova K
    Neoplasma; 2010; 57(3):215-21. PubMed ID: 20353271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
    Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
    Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.
    Grabowski P; Hultdin M; Karlsson K; Tobin G; Aleskog A; Thunberg U; Laurell A; Sundström C; Rosenquist R; Roos G
    Blood; 2005 Jun; 105(12):4807-12. PubMed ID: 15746080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age.
    Son NH; Murray S; Yanovski J; Hodes RJ; Weng N
    J Immunol; 2000 Aug; 165(3):1191-6. PubMed ID: 10903716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
    Hoxha M; Fabris S; Agnelli L; Bollati V; Cutrona G; Matis S; Recchia AG; Gentile M; Cortelezzi A; Morabito F; Bertazzi PA; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2014 Jul; 53(7):612-21. PubMed ID: 24706380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.
    Salin H; Ricoul M; Morat L; Sabatier L
    Cytogenet Genome Res; 2008; 122(3-4):343-9. PubMed ID: 19188704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
    Lin TT; Letsolo BT; Jones RE; Rowson J; Pratt G; Hewamana S; Fegan C; Pepper C; Baird DM
    Blood; 2010 Sep; 116(11):1899-907. PubMed ID: 20538793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.